Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions

Bevacizumab Inhibits Breast Cancer-Induced Osteolysis, Surrounding Soft Tissue Metastasis, and Angiogenesis in Rats as Visualized by VCT and MRI

(2015) Tobias Bäuerle et al.   NEOPLASIA

Serum bone sialoprotein levels and bone metastases

(2011) Mario Uccello et al.   Journal of Cancer Research and Therapeutics

Osteopontin: An Effector and an Effect of Tumor Metastasis

(2010) L. Shevde et al.   CURRENT MOLECULAR MEDICINE

Biodistribution of antisense nanoparticles in mammary carcinoma rat model

(2010) Victoria Elazar et al.   DRUG DELIVERY

Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development

(2010) A. Bellahcène et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

(2010) Mark E. Davis et al.   NATURE

miRNA-Mediated Functional Changes through Co-Regulating Function Related Genes

(2010) Jie He et al.   PLoS One

Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells

(2009) Ji S. Park et al.   BIOMATERIALS

Trastuzumab: A Picky Partner?

(2009) H. L. McArthur et al.   CLINICAL CANCER RESEARCH

Bone sialoprotein stimulates focal adhesion-related signaling pathways: Role in migration and survival of breast and prostate cancer cells

(2009) Jonathan A.R. Gordon et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Genes that mediate breast cancer metastasis to the brain

(2009) Paula D. Bos et al.   NATURE

Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1

(2008) Benjamin D. Hedley et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of siRNA specificity on targets with double-nucleotide mismatches

(2008) Cecilia Dahlgren et al.   NUCLEIC ACIDS RESEARCH